13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)

Page 7 of 9 – SEC Filing

 

 

CUSIP
No
.
713661502   Page
7 of 9

 

Item
4.
Ownership.
   
  Provide
the following information regarding the aggregate number and percentage of the class of securities of the issuer identified
in Item 1.
   
  (a) Amount
beneficially owned:
Aggregate of all filers—2,298,684
    Tappan
Street Partners LLC —2,231,577
    Tappan
Street Partners Fund L.P. —1,540,000
    Tappan
Street Partners Ideas Fund L.P. —691,577
    Prasad
Phatak—2,298,684*
     
  (b) Percent
of class:
Aggregate of all filers—5.10%
    Tappan
Street Partners LLC—4.95%
    Tappan
Street Partners Fund L.P.—3.42%
    Tappan
Street Partners Ideas Fund L.P. ——1.53%
    Prasad
Phatak—5.10%*
     
  (c) Number
of shares as to which such person has:
     
    (i) Sole
power to vote or to direct the vote:
      Tappan
Street Partners LLC —0
      Tappan
Street Partners Fund L. P. —0
      Tappan
Street Partners Ideas Fund L. P. —0
      Prasad
Phatak—67,107
       
    (ii) Shared
power to vote or to direct the vote:
      Tappan
Street Partners LLC —2,231,577
      Tappan
Street Partners Fund L. P. —1,540,000
      Tappan
Street Partners Ideas Fund L. P. —691,577
      Prasad
Phatak—2,231,577*
       
    (iii) Sole
power to dispose or to direct the disposition of
      Tappan
Street Partners LLC —0
      Tappan
Street Partners Fund L. P. —0
      Tappan
Street Partners Ideas Fund L. P. —0
      Prasad
Phatak—67,107
       
    (iv) Shared
power to dispose or to direct the disposition of:
      Tappan
Street Partners LLC —2,231,577
      Tappan
Street Partners Fund L. P. —1,540,000
      Tappan
Street Partners Ideas Fund L. P. —691,577
      Prasad
Phatak—2,231,577*
       
       

*Mr.
Phatak is the managing member of Tappan Street Partners LLC. As a result, Mr. Phatak possesses the power to vote and dispose or
direct the disposition of all the shares beneficially owned by Tappan Street Partners LLC as investment manager to the Funds.
Mr. Phatak disclaims beneficial ownership of any of the shares held by the Funds.

Follow Avid Bioservices Inc. (NASDAQ:CDMO)